Iliyan Ivanov, MD
- ASSOCIATE PROFESSOR | Psychiatry
Specialty:Child and Adolescent Psychiatry
Financial & Billing Information
Please direct any detailed billing or financial inquires to the Mount Sinai Psychiatry billing customer service number at 212-659-8752.
- Alcohol Abuse And Alcoholism
- Attention Deficit Hyperactivity Disorder And Attention Deficit Disorder
- Drug Abuse And Drug Addiction
- Magnetic Resonance Imaging
- Post-Traumatic Stress Disorder
MD, Higher Medical Institute Varna
Residency, Psychiatry, Maimonides Medical Center
Residency, Psychiatry, The Mount Sinai Hospital
Fellowship, Child and Adolescent Psychiatry, The Mount Sinai Hospital
Using fMRI to identify biological markers of vulnerability for adolescent substance abuse; investigating the effect of stimulant treatment for children with ADHD as a risk factor for the development of addiction later in life; studying the impact of childhood trauma on biological systems.
Keywords - ADHD, adolescent substance abuse, HPA, cortisol, inhibitory control, reward system
Ivanov I, Charney A. Current trends in the use of antipsychotics in pediatric patients [review]. The Mount Sinai Journal of Medicine 2008 May-June; 75(3): 276-286.
Ivanov I, Schulz K, London E. Inhibitory Control Deficits in Childhood and Risk for Substance Use Disorders. The American Journal of Drug and Alcohol Abuse 2008; 34(3): 239-258.
Newcorn J, Ivanov I. Psychopharmacological Treatment of Attention-Deficit/Hyperactivity Disorder and Disruptive Behavior Disorders-review. In: Arnold L, editor. Special Issue on Pediatric Psychopharmacology (July 2007). Psychiatric Annals; pp37(7).
Ivanov I. Common Problems in Psychotherapy Training for Psychiatry Residents. Journal of Psychiatric Practice 2007 May; 13(3): 184-189.
Ivanov I, Klein M, Green WH. The Challenges of Psychopharmacological Management of Children with Severe Developmental Disabilities: a Clinical Case. Journal of Child and Adolescent Psychopharmacology 2006 Dec; 16(6): 793-799.
Ivanov I, Schulz KP, Palmero R, Newcorn JH. Neurobiology and Evidence-based Treatments for Substance Abuse Disorders- Review. CNS Spectrums 2006 Nov; 11(11): 864-877.
Newcorn J, Ivanov I. Risk-Benefit Considerations in ADHD Pharmacotherapy, First Report. Princeton CME 2006 Oct;.
Ivanov I. Case Study Childhood Onset Conduct Disorder for Psychiatry Pearls (2004). Philadelphia, PA, Hanley & Belfus, Inc.;.
Ivanov I. Case Study ADHD/Bipolar Disorder Co-morbidity in Children for Psychiatry Pearls (2004). Philadelphia, PA, Hanley & Belfus, Inc.;.
Newcorn JH, Miller SR, Ivanov I, Schulz KP, Marks D, Halperin JM. Adolescent Outcome of ADHD: Impact of Childhood Conduct and Anxiety Disorders. CNS Spectrums 2004 Sep; 9(9): 668-678.